Clinical trial
A Study to Assess the Efficacy and Safety of ABTL0812
NCT03366480
Study timeline
Study start (actual)2016-12-01Date precision: day
Registry last updated2023-02-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Endometrial Cancerunresolved
Squamous Non-Small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
Ability Pharmaceuticals SLlead sponsor
Hospital Vall d'Hebroncollaborator
Institut Català d'Oncologiacollaborator
Hospital Clínico Universitario de Valenciacollaborator
Hospitales Universitarios Virgen del Rocíocollaborator
Centre Leon Berardcollaborator
Institut Paoli-Calmettescollaborator
Gustave Roussy, Cancer Campus, Grand Pariscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03366480 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.